Healthcare
Myriad Genetics, Inc.
MYGNPrice is delayed.
About Myriad Genetics, Inc.
Myriad Genetics develops DNA tests that help doctors understand a patient's health risks and choose better treatments. The company makes tests for cancer risk (like the MyRisk test for hereditary cancers), tests that analyze tumors to predict how aggressive they are, and tests that help doctors pick the right psychiatric medications based on a patient's genes. They also offer prenatal tests that check a fetus for genetic problems or tell expecting parents if they carry genes for conditions they could pass to their children. Hospitals and doctors order these tests to give patients more personal...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore